Terminology Service for NFDI4Health
All terms in CLO
| Label | Id | Description |
|---|---|---|
| ND11191 cell | CLO_0020347 | [ POPULATION/CONVENIENCE CONTROL] |
| LN-229 cell | CLO_0007363 | [disease: glioblastoma; apoptosis studies; p53+, p16, p14ARF] |
| ND11184 cell | CLO_0020340 | [ POPULATION/CONVENIENCE CONTROL] |
| ND11183 cell | CLO_0020341 | [ POPULATION/CONVENIENCE CONTROL] |
| L-NGC-alpha2B L-cells cell | CLO_0007369 | |
| ND11186 cell | CLO_0020342 | [ POPULATION/CONVENIENCE CONTROL] |
| L-NGC-5HT2 cell | CLO_0007368 | |
| entire sense organ system | UBERON_0004456 | |
| ND11185 cell | CLO_0020343 | [ POPULATION/CONVENIENCE CONTROL] |
| LNCaP.FGC cell | CLO_0007367 | |
| ND10660 cell | CLO_0034980 | [ POPULATION/CONVENIENCE CONTROL] |
| ND11192 cell | CLO_0020348 | [ POPULATION/CONVENIENCE CONTROL] |
| Lo Wen cell | CLO_0007373 | [disease: xeroderma pigmentosum, presumed heterozygote] |
| Lo Ren cell | CLO_0007372 | [disease: Ehlers-Danlos syndrome, type I (autosomal dominant type)] |
| ND11174 cell | CLO_0020349 | [ POPULATION/CONVENIENCE CONTROL] |
| LNZTA3WT4 cell | CLO_0007371 | [disease: glioblastoma; p53 expression under tetracycline-induced promoter] |
| LNZTA3WT11 cell | CLO_0007370 | [disease: glioblastoma; p53 expression under tetracycline-induced promoter] |
| ND10664 cell | CLO_0034985 | [ AMYOTROPHIC LATERAL SCLEROSIS] |
| ND09698 cell | CLO_0032322 | [ AMYOTROPHIC LATERAL SCLEROSIS] |
| ND11480 cell | CLO_0019344 | [ ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS AMYOTROPHIC LATERAL SCLEROSIS] |